Trial Profile
A multicentre, non-interventional, non controlled, observational study to evaluate the safety, tolerability, compliance and effectiveness of a fixed dose combination of Omlesartan/Amlodipine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 21 Dec 2015 New trial record